Alpha Tau Medical Says A Patient With Advanced Inoperable Pancreatic Cancer Using Its Alpha-radiation Cancer Therapy Alpha DaRT Has Been Treated In A Clinical Trial At Hadassah Medical Center In Israel
Portfolio Pulse from Benzinga Newsdesk
Alpha Tau Medical has treated a patient with advanced inoperable pancreatic cancer using its Alpha-radiation Cancer Therapy Alpha DaRT in a clinical trial at Hadassah Medical Center in Israel. The trial is designed for a broad range of solid tumor patients who do not qualify for other existing trials or do not have other treatment options.
September 14, 2023 | 12:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alpha Tau Medical's clinical trial using Alpha DaRT could potentially impact the stock of DRTS.
The successful application of Alpha Tau Medical's Alpha DaRT in a clinical trial could potentially lead to increased investor confidence in DRTS, leading to a potential increase in stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80